Clinical Trials

Ongoing Clinical Trials



SCYNERGIA

A Phase 2 Trial - Combination Therapy of Ibrexafungerp (SCY-078) with Voriconazole in Patients with Invasive Pulmonary Aspergillosis

Learn more here



FURI

Open-Label Study to Evaluate the Efficacy and Safety of Ibrexafungerp (SCY-078) in Patients with Refractory or Intolerant Fungal Diseases

Learn more here



CARES

Open-Label Study to Evaluate the Efficacy and Safety of Ibrexafungerp (SCY-078) in Patients with Candidiasis Caused by Candida Auris

Learn more here



VANISH-303

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects with Acute Vulvovaginal Candidiasis

Learn more here



VANISH-306

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects with Acute Vulvovaginal Candidiasis

Learn more here



CANDLE

A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral ibrexafungerp (SCY-078) vs. Placebo in female subjects with recurrent VVC (RVVC)

Learn more here

Interested In Our Clinical Trials?

Interested In:


If you have any questions, please contact us at ClinicalTrials@SCYNEXIS.com.